BETA Winter/Spring 2008


In this issue, Liz Highleyman addresses two timely and important topics: when to start anti-HIV treatment, and what to start with. A feature article by psychotherapists Gaetano Vaccaro and Joni Lavick discusses the well-researched connections between HIV and physical, emotional, or sexual trauma, and describes numerous treatment options that have offered relief to their own HIV positive clients. And in the Women and HIV column, Naina Khanna of WORLD talks about the new National Positive Women’s Network, a support and leadership organization that recognizes HIV positive women as the experts in their own lives.

Readers will also find an article on what counts as evidence in evidence-based HIV prevention, and how that evidence is usedor notin prevention programs. As authors Judith D. Auerbach and William Smith explain, HIV prevention might be better served by a notion of evidence that goes beyond the results of scientific studies to include the knowledge gained from the lived experience of individuals and communities affected by HIV/AIDS.

Read more...

HIV Associated Pneumonias

Throughout our lives, we all experience significant events that impact our perceptions of the world and determine how we interpret and respond to future experiences. These events elicit powerful thoughts, emotions, and physical sensations that can become imprinted upon the mind. They are moments frozen in time. Read more...

Smoking and Your Health: How to Quit (And Why You Should)’

By now, it is firmly established that smoking is a major risk factor for serious chronic illnesses, including cardiovascular disease and cancer. In the early years of the epidemic, many people with HIV/AIDS assumed there was little point in worrying about chronic progressive diseases, since they probably would not live long enough for these to develop. Read more...

News Briefs

Three major scientific meetings on HIV/AIDS have taken place since the last issue of BETA: the 4th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment, and Prevention, held in Sydney, Australia, in July; the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in Chicago in September; and the 11th European AIDS Conference (EACS), held in Madrid, Spain, in October. Read more...

Drug Watch: Next-Generation NNRTIs: Etravirine and Rilpivirine

"Even in patients with the most resistant virus, our goal now is full suppression of HIV replication," said Joseph Eron, MD, during a plenary session at the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Dr. Eron, Principal Investigator of the AIDS Clinical Research Group at the University of North Carolina, Chapel Hill, observed that in industrialized nations, up to 10% of HIV positive individuals receiving medical care have triple-class drug-resistant virus. Read more...

Women and HIV: A Conversation with Dr. Nancy Padian

Around the globe, countless women are unable to protect themselves from HIV-largely because they lack access to condoms or can’t count on their male sex partners to use condoms consistently. Potentially life-saving HIV prevention interventions are being developed with these women in mind, including microbicides and other protective products that can be used with or without a partner’s knowledge, as well as strategies for boosting women’s control over how and with whom they have sex. Read more...

Open Clinical Trials

Below is a selected list of currently enrolling clinical trials gathered from various sources. The federal government’s AIDSinfo website includes a clinical trials section that features an introduction to HIV/ AIDS research and study listings from the National Institutes of Health’s ClinicalTrials.gov database. AIDSinfo also offers personalized advice about clinical trial participation via email (ContactUs@AIDSinfo.nih.gov), an interactive website (www.aidsinfo.nih.gov/live_help), and a toll-free telephone service (800-448-0440, international 301-315- 2816). Read more...

HAART Chart - Approved Antiretroviral Drugs

Read more...


Get Adobe Reader

Having trouble reading these articles?

These articles are published as PDFs, for which you need some version of the Adobe Reader. You can click on the image to the right to download it if you don't have it.

If your browser won't let you open those links, please let us know.

Keep Exploring

Get Tested

The best way to fight HIV is to know your status. A simple test can determine if you are infected with the virus.

Learn more...

Our Work

Our diverse programs help thousands of people every year. From testing to prevention to care, our services assist communities where need is greatest.

See what we're doing...

Our Blog

Keep up with what's happening now in the fight against HIV from foundation experts.

Check it out...

 

Contact Us

415/487-3000
415/487-8079 (FAX)

San Francisco AIDS Foundation

1035 Market St
Suite 400
San Francisco CA
94103